Literature DB >> 8970600

Diagnosis and treatment of uveal melanoma.

J A Shields1, C L Shields, P De Potter, A D Singh.   

Abstract

Most malignant melanomas in the ocular region arise in the uveal tract (iris, ciliary body, and choroid). Uveal melanoma generally has characteristic clinical features and the diagnosis can usually be made by an experienced ophthalmologist using slit lamp biomicroscopy or indirect ophthalmoscopy. Ancillary studies such as fluorescein angiography, ultrasonography, magnetic resonance imaging, and fine needle biopsy can occasionally be used to establish the diagnosis in atypical cases. Today, most affected patients are managed by specialists in ocular oncology. The management of uveal melanoma has been the subject of considerable controversy. Iris melanoma can usually be excised without enucleation of the affected eye. With regard to posterior uveal melanoma (ciliary body and choroid), enucleation of the affected eye was once the undisputed method of treatment. More recently, however, removal of the eye is performed less often and alternatives to enucleation have gained popularity. Several years ago, laser photocoagulation and plaque brachytherapy were the most popular alternatives to enucleation. Now, techniques of local tumor excision and transpupillary thermotherapy are gaining popularity in selected cases. Even more recently, various combinations of these methods have been judiciously used in many instances. The selected method of treatment in a given case depends on a number of complex clinical factors. Philosophies regarding the management of these lesions continue to change. This review covers the current diagnosis and management of uveal melanoma with emphasis on methods of management.

Entities:  

Mesh:

Year:  1996        PMID: 8970600

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  11 in total

1.  High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.

Authors:  Akira Yamamoto; Inna Chervoneva; Kevin L Sullivan; David J Eschelman; Carin F Gonsalves; Michael J Mastrangelo; David Berd; Jerry A Shields; Carol L Shields; Mizue Terai; Takami Sato
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

2.  Multimode imaging characteristics and treatment of uveal schwannoma.

Authors:  Ting Zhang; Lu-Jia Feng; You Wang; Yun-Hong Shi; Li Wang; Yi-Meng Sun; Yan-Tao Wei; Shao-Chong Zhang
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

3.  Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.

Authors:  P Terheyden; E B Bröcker; J C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

Review 4.  MR-Eye: High-Resolution Microscopy Coil MRI for the Assessment of the Orbit and Periorbital Structures, Part 2: Clinical Applications.

Authors:  N W Dobbs; M J Budak; R D White; I A Zealley
Journal:  AJNR Am J Neuroradiol       Date:  2021-03-18       Impact factor: 4.966

5.  Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.

Authors:  J C Becker; P Terheyden; E Kämpgen; S Wagner; C Neumann; D Schadendorf; A Steinmann; G Wittenberg; W Lieb; E-B Bröcker
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

Review 6.  Proteomics of uveal melanoma: a minireview.

Authors:  Søren K O Abildgaard; Henrik Vorum
Journal:  J Oncol       Date:  2013-09-03       Impact factor: 4.375

7.  Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan.

Authors:  Jason C Hsu; Luis A Gonzalez-Gonzalez; Vicky H Lu; Christine Y Lu
Journal:  BMJ Open       Date:  2016-05-27       Impact factor: 2.692

8.  Identification of novel chemotherapeutic strategies for metastatic uveal melanoma.

Authors:  Paolo Fagone; Rosario Caltabiano; Andrea Russo; Gabriella Lupo; Carmelina Daniela Anfuso; Maria Sofia Basile; Antonio Longo; Ferdinando Nicoletti; Rocco De Pasquale; Massimo Libra; Michele Reibaldi
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

9.  Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma.

Authors:  Yuanyuan Zhang; Yong Yang; Lei Chen; Jianhong Zhang
Journal:  BMC Med Genet       Date:  2014-03-05       Impact factor: 2.103

10.  Prognostic factors of choroidal melanoma in Slovenia, 1986-2008.

Authors:  Boris Jancar; Marjan Budihna; Brigita Drnovsek-Olup; Katrina Novak Andrejcic; Irena Brovet Zupancic; Dusica Pahor
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.